Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside
出版年份 2013 全文链接
标题
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside
作者
关键词
Metastatic sites, Patient outcome, Primary tumor, Renal cell carcinoma, Targeted therapy, Tumor heterogeneity
出版物
CANCER AND METASTASIS REVIEWS
Volume 33, Issue 1, Pages 321-331
出版商
Springer Nature
发表日期
2013-12-12
DOI
10.1007/s10555-013-9453-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Vascularity of primary and metastatic renal cell carcinoma specimens
- (2013) Saadia A Aziz et al. Journal of Translational Medicine
- Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey
- (2013) Daniele Santini et al. PLoS One
- The Impact of Tyrosine Kinase Inhibitors on the Multimodality Treatment of Brain Metastases From Renal Cell Carcinoma
- (2012) Jonathan Verma et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST
- (2012) Mizuki Nishino et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
- (2012) B Beuselinck et al. BRITISH JOURNAL OF CANCER
- Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor
- (2012) Xun Xu et al. CELL
- Brain Metastases from Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors
- (2012) Arkadiusz Z. Dudek et al. Clinical Genitourinary Cancer
- Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: Analysis of response and progression-free survival in the RECORD-1 study
- (2012) Stéphane Oudard et al. EUROPEAN JOURNAL OF CANCER
- Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
- (2012) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery
- (2012) D. Clay Cochran et al. JOURNAL OF NEUROSURGERY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
- (2011) M. Bianchi et al. ANNALS OF ONCOLOGY
- Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma
- (2011) Jonathan Verma et al. CANCER
- Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases
- (2011) Osama Hussein et al. CANCER LETTERS
- Comparison of Four Early Posttherapy Imaging Changes (EPTIC; RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor–Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
- (2011) Katherine M. Krajewski et al. EUROPEAN UROLOGY
- Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function
- (2011) Shinya Maita et al. INTERNATIONAL JOURNAL OF CANCER
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Course of size and density of metastatic renal cell carcinoma lesions in the early follow-up of molecular targeted therapy
- (2011) Markus Hittinger et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Pancreatic metastases from renal cell carcinoma: The state of the art
- (2011) Roberto Ballarin WORLD JOURNAL OF GASTROENTEROLOGY
- Morphology, Attenuation, Size, and Structure (MASS) Criteria: Assessing Response and Predicting Clinical Outcome in Metastatic Renal Cell Carcinoma on Antiangiogenic Targeted Therapy
- (2010) Andrew Dennis Smith et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib
- (2010) B. Beuselinck et al. ANNALS OF ONCOLOGY
- Skeletal complications and survival in renal cancer patients with bone metastases
- (2010) Emma Woodward et al. BONE
- Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
- (2010) A A M van der Veldt et al. BRITISH JOURNAL OF CANCER
- Sunitinib in metastatic renal cell carcinoma patients with brain metastases
- (2010) Martin E. Gore et al. CANCER
- The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases
- (2010) Tamer Abou Youssif et al. CANCER
- Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
- (2010) Walter M. Stadler et al. CANCER
- EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
- (2010) Börje Ljungberg et al. EUROPEAN UROLOGY
- Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma
- (2010) E. Jason Abel et al. EUROPEAN UROLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Effect of Temsirolimus against Oral Squamous Cell Carcinoma Associated with Bone Destruction
- (2010) T. Okui et al. MOLECULAR CANCER THERAPEUTICS
- Assessing Tumor Response and Detecting Recurrence in Metastatic Renal Cell Carcinoma on Targeted Therapy: Importance of Size and Attenuation on Contrast-Enhanced CT
- (2009) Andrew Dennis Smith et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib
- (2009) R. Thiam et al. ANNALS OF ONCOLOGY
- Efficacy of targeted therapy in patients with renal cell carcinoma with pre-existing or new bone metastases
- (2009) Jakub Żołnierek et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Response of Renal Cell Carcinoma Pancreatic Metastasis to Sunitinib Treatment: A Retrospective Analysis
- (2009) Jacques Medioni et al. JOURNAL OF UROLOGY
- Sorafenib for Metastatic Renal Cancer
- (2008) Rachel P. Riechelmann et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm
- (2008) Brian Shuch et al. BJU INTERNATIONAL
- Sunitinib for Treatment of Advanced Renal Cell Cancer: Primary Tumor Response
- (2008) A. A.M. van der Veldt et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma
- (2008) Anil A. Thomas et al. JOURNAL OF UROLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Preoperative Tyrosine Kinase Inhibition as an Adjunct to Debulking Nephrectomy
- (2008) Chirag Amin et al. UROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started